{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:44:25Z","timestamp":1793825065053,"version":"4.6.1"},"reference-count":98,"publisher":"Georg Thieme Verlag KG","issue":"01","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Respir Crit Care Med"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Allergic bronchopulmonary aspergillosis (ABPA) is a complex hypersensitivity reaction to airway colonization by Aspergillus fumigatus in patients with asthma and cystic fibrosis. The pathophysiology of ABPA involves a complex interplay between the fungus and the host immune response, which causes persistent inflammation and tissue damage. Patients present with chronic cough, wheezing, and dyspnea due to uncontrolled asthma. Characteristic symptoms include the expectoration of brownish mucus plugs. Radiographic findings often reveal fleeting pulmonary infiltrates, bronchiectasis, and mucus impaction. However, the definitive diagnosis of ABPA requires a combination of clinical, radiological, and immunological findings. The management of ABPA aims to reduce symptoms, prevent disease progression, and minimize the future risk of exacerbations. The treatment approach involves systemic glucocorticoids or antifungal agents to suppress the inflammatory response or fungal growth and prevent exacerbations. Biological agents may be used in patients with severe disease or glucocorticoid dependence. This review provides an overview of the clinical manifestations and current treatment options for ABPA.<\/jats:p>","DOI":"10.1055\/s-0043-1776912","type":"journal-article","created":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T23:44:22Z","timestamp":1703807062000},"page":"114-127","source":"Crossref","is-referenced-by-count":27,"title":["Clinical Manifestation and Treatment of Allergic Bronchopulmonary Aspergillosis"],"prefix":"10.1055","volume":"45","author":[{"given":"Ritesh","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valliappan","family":"Muthu","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inderpaul S.","family":"Sehgal","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2023,12,28]]},"reference":[{"issue":"06","key":"ref1","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/j.jaip.2023.04.009","article-title":"Prevalence of aspergillus sensitization and allergic bronchopulmonary aspergillosis in adults with bronchial asthma: a systematic review of global data","volume":"11","author":"R Agarwal","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"05","key":"ref2","doi-asserted-by":"crossref","first-page":"922","DOI":"10.3390\/diagnostics13050922","article-title":"Aspergillus sensitization and allergic bronchopulmonary aspergillosis in asthmatic children: a systematic review and meta-analysis","volume":"13","author":"R Agarwal","year":"2023","journal-title":"Diagnostics (Basel)"},{"issue":"07","key":"ref3","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/cea.14299","article-title":"Population prevalence of allergic bronchopulmonary aspergillosis in asthma: an epidemiological study of 43,261 participants from North India","volume":"53","author":"K Soundappan","year":"2023","journal-title":"Clin Exp Allergy"},{"issue":"05","key":"ref4","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1067\/mai.2003.1395","article-title":"Association of polymorphisms in the collagen region of SP-A2 with increased levels of total IgE antibodies and eosinophilia in patients with allergic bronchopulmonary aspergillosis","volume":"111","author":"S Saxena","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13223-016-0152-y","article-title":"Genetic susceptibility to allergic bronchopulmonary aspergillosis in asthma: a genetic association study","volume":"12","author":"N L Overton","year":"2016","journal-title":"Allergy Asthma Clin Immunol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11046-022-00631-y","article-title":"Occurrence of cystic fibrosis transmembrane conductance regulator gene mutations in patients with allergic bronchopulmonary aspergillosis complicating asthma","volume":"187","author":"R Kanaujia","year":"2022","journal-title":"Mycopathologia"},{"issue":"03","key":"ref7","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1046\/j.1365-2249.2000.01232.x","article-title":"Cytokine dysregulation in activated cystic fibrosis (CF) peripheral lymphocytes","volume":"120","author":"R B Moss","year":"2000","journal-title":"Clin Exp Immunol"},{"issue":"22","key":"ref8","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1007\/s00018-020-03540-9","article-title":"Dysregulated signalling pathways in innate immune cells with cystic fibrosis mutations","volume":"77","author":"S Lara-Reyna","year":"2020","journal-title":"Cell Mol Life Sci"},{"issue":"S 27","key":"ref9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/pai.13619","article-title":"Type 2 inflammation in cystic fibrosis: new insights","volume":"33","author":"S Manti","year":"2022","journal-title":"Pediatr Allergy Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.2741\/990","article-title":"Immunopathogenesis of allergic bronchopulmonary aspergillosis and airway remodeling","volume":"8","author":"H F Kauffman","year":"2003","journal-title":"Front Biosci"},{"issue":"7259","key":"ref11","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/nature08264","article-title":"Surface hydrophobin prevents immune recognition of airborne fungal spores","volume":"460","author":"V Aimanianda","year":"2009","journal-title":"Nature"},{"issue":"01","key":"ref12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ccm.2021.12.002","article-title":"Allergic bronchopulmonary aspergillosis","volume":"43","author":"R Agarwal","year":"2022","journal-title":"Clin Chest Med"},{"issue":"02","key":"ref13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/jof2020017","article-title":"Allergic bronchopulmonary aspergillosis","volume":"2","author":"M C Tracy","year":"2016","journal-title":"J Fungi (Basel)"},{"issue":"03","key":"ref14","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.alit.2015.04.004","article-title":"ILC2s and fungal allergy","volume":"64","author":"H Kita","year":"2015","journal-title":"Allergol Int"},{"issue":"6442","key":"ref15","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1126\/science.aaw4295","article-title":"Protein crystallization promotes type 2 immunity and is reversible by antibody treatment","volume":"364","author":"E K Persson","year":"2019","journal-title":"Science"},{"issue":"02","key":"ref16","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jaci.2017.07.048","article-title":"Eosinophils release extracellular DNA traps in response to Aspergillus fumigatus","volume":"141","author":"V S Muniz","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"04","key":"ref17","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1378\/chest.07-0808","article-title":"Clinical significance of hyperattenuating mucoid impaction in allergic bronchopulmonary aspergillosis: an analysis of 155 patients","volume":"132","author":"R Agarwal","year":"2007","journal-title":"Chest"},{"issue":"02","key":"ref18","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.rmed.2009.09.005","article-title":"Clinical significance of decline in serum IgE levels in allergic bronchopulmonary aspergillosis","volume":"104","author":"R Agarwal","year":"2010","journal-title":"Respir Med"},{"key":"ref19","first-page":"186","article-title":"Bronchopulmonary aspergillosis. A correlation of the clinical and laboratory findings in 272 patients investigated for bronchopulmonary aspergillosis","volume":"89","author":"M J Campbell","year":"1964","journal-title":"Am Rev Respir Dis"},{"issue":"06","key":"ref20","doi-asserted-by":"crossref","first-page":"2102218","DOI":"10.1183\/13993003.02218-2021","article-title":"Nebulised liposomal amphotericin-B as maintenance therapy in allergic bronchopulmonary aspergillosis: a randomised, multicentre trial","volume":"59","author":"C Godet","year":"2022","journal-title":"Eur Respir J"},{"issue":"02","key":"ref21","first-page":"73","article-title":"Allergic bronchopulmonary aspergillosis: a study of 46 cases with special reference to laboratory aspects","volume":"57","author":"Z U Khan","year":"1976","journal-title":"Scand J Respir Dis"},{"issue":"04","key":"ref22","first-page":"181","article-title":"Prevalence of allergic bronchopulmonary aspergillosis in patients with bronchial asthma","volume":"18","author":"R Kumar","year":"2000","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"01","key":"ref23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/myc.13388","article-title":"Epidemiology and outcomes of allergic bronchopulmonary aspergillosis in the elderly","volume":"65","author":"V Muthu","year":"2022","journal-title":"Mycoses"},{"issue":"01","key":"ref24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.alit.2017.04.011","article-title":"Allergic bronchopulmonary aspergillosis in Japan: a nationwide survey","volume":"67","author":"T Oguma","year":"2018","journal-title":"Allergol Int"},{"key":"ref25","first-page":"OC12","article-title":"Allergic bronchopulmonary aspergillosis in acute severe asthma - a cross-sectional study","volume":"14","author":"A Shahul","year":"2020","journal-title":"J Clin Diagn Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2147\/JAA.S345427","article-title":"Clinical characteristics and prognosis of allergic bronchopulmonary aspergillosis: a retrospective cohort study","volume":"15","author":"Y Zeng","year":"2022","journal-title":"J Asthma Allergy"},{"issue":"05","key":"ref27","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/crj.13147","article-title":"Clinical characteristics of allergic bronchopulmonary aspergillosis","volume":"14","author":"C Zhang","year":"2020","journal-title":"Clin Respir J"},{"issue":"02","key":"ref28","first-page":"260","article-title":"Allergic bronchopulmonary aspergillosis (ABPA) sans asthma: a distinct subset of ABPA with a lesser risk of exacerbation","volume":"58","author":"V Muthu","year":"2020","journal-title":"Med Mycol"},{"issue":"01","key":"ref29","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1186\/s12890-021-01789-9","article-title":"Total unilateral pulmonary collapse secondary to allergic bronchopulmonary aspergillosis: a case series of an unusual cause of complete atelectasis","volume":"21","author":"N Benkalfate","year":"2021","journal-title":"BMC Pulm Med"},{"issue":"04","key":"ref30","doi-asserted-by":"crossref","first-page":"e223","DOI":"10.1111\/j.1439-0507.2009.01830.x","article-title":"A rare cause of acute respiratory failure\u2013allergic bronchopulmonary aspergillosis","volume":"54","author":"R Agarwal","year":"2011","journal-title":"Mycoses"},{"issue":"01","key":"ref31","first-page":"37","article-title":"Pulmonary hypertension as a presenting manifestation of allergic bronchopulmonary aspergillosis","volume":"51","author":"R Agarwal","year":"2009","journal-title":"Indian J Chest Dis Allied Sci"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"bcr2015211493","DOI":"10.1136\/bcr-2015-211493","article-title":"Allergic bronchopulmonary aspergillosis in an adult with Kartagener syndrome","volume":"2015","author":"I S Sehgal","year":"2015","journal-title":"BMJ Case Rep"},{"issue":"05","key":"ref33","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1378\/chest.15-0069","article-title":"Specific IgE is better than skin testing for detecting Aspergillus sensitization and allergic bronchopulmonary aspergillosis in asthma","volume":"147","author":"I S Sehgal","year":"2015","journal-title":"Chest"},{"issue":"12","key":"ref34","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0009-9260(05)83104-6","article-title":"Accuracy of CT in predicting the cause of bronchiectasis","volume":"50","author":"P H Lee","year":"1995","journal-title":"Clin Radiol"},{"issue":"02","key":"ref35","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2214\/ajr.165.2.7618537","article-title":"CT findings in bronchiectasis: limited value in distinguishing between idiopathic and specific types","volume":"165","author":"D B Reiff","year":"1995","journal-title":"AJR Am J Roentgenol"},{"issue":"01","key":"ref36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2214\/ajr.173.1.10397098","article-title":"Bronchiectasis: accuracy of high-resolution CT in the differentiation of specific diseases","volume":"173","author":"Y Cartier","year":"1999","journal-title":"AJR Am J Roentgenol"},{"issue":"04","key":"ref37","doi-asserted-by":"crossref","first-page":"e61105","DOI":"10.1371\/journal.pone.0061105","article-title":"Diagnostic performance of various tests and criteria employed in allergic bronchopulmonary aspergillosis: a latent class analysis","volume":"8","author":"R Agarwal","year":"2013","journal-title":"PLoS One"},{"issue":"01","key":"ref38","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jaip.2020.08.043","article-title":"Which are the optimal criteria for the diagnosis of allergic bronchopulmonary aspergillosis? A latent class analysis","volume":"9","author":"P Saxena","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"09","key":"ref39","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/cea.13216","article-title":"Utility of recombinant Aspergillus fumigatus antigens in the diagnosis of allergic bronchopulmonary aspergillosis: a systematic review and diagnostic test accuracy meta-analysis","volume":"48","author":"V Muthu","year":"2018","journal-title":"Clin Exp Allergy"},{"issue":"09","key":"ref40","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/myc.13124","article-title":"Role of recombinant Aspergillus fumigatus antigens in diagnosing Aspergillus sensitisation among asthmatics","volume":"63","author":"V Muthu","year":"2020","journal-title":"Mycoses"},{"issue":"01","key":"ref41","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1939-4551-6-17","article-title":"A WAO - ARIA - GA2LEN consensus document on molecular-based allergy diagnostics","volume":"6","author":"G W Canonica","year":"2013","journal-title":"World Allergy Organ J"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molimm.2018.03.003","article-title":"WHO\/IUIS allergen nomenclature: providing a common language","volume":"100","author":"A Pom\u00e9s","year":"2018","journal-title":"Mol Immunol"},{"issue":"04","key":"ref43","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.alit.2015.05.007","article-title":"Sensitization to fungal allergens: resolved and unresolved issues","volume":"64","author":"Y Fukutomi","year":"2015","journal-title":"Allergol Int"},{"issue":"01","key":"ref44","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.alit.2015.08.004","article-title":"Serological diagnosis of allergic bronchopulmonary mycosis: progress and challenges","volume":"65","author":"Y Fukutomi","year":"2016","journal-title":"Allergol Int"},{"issue":"02","key":"ref45","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jaip.2019.08.041","article-title":"Diagnostic cutoffs and clinical utility of recombinant Aspergillus fumigatus antigens in the diagnosis of allergic bronchopulmonary aspergillosis","volume":"8","author":"V Muthu","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"03","key":"ref46","doi-asserted-by":"crossref","first-page":"1700629","DOI":"10.1183\/13993003.00629-2017","article-title":"European Respiratory Society guidelines for the management of adult bronchiectasis","volume":"50","author":"E Polverino","year":"2017","journal-title":"Eur Respir J"},{"issue":"03","key":"ref47","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1016\/j.chest.2020.09.276","article-title":"A young girl with bronchiectasis and elevated sweat chloride","volume":"159","author":"I S Sehgal","year":"2021","journal-title":"Chest"},{"issue":"03","key":"ref48","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.anai.2013.06.022","article-title":"Dissociation between sensitizing and colonizing fungi in patients with allergic bronchopulmonary aspergillosis","volume":"111","author":"H Matsuse","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"04","key":"ref49","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.jaci.2020.08.029","article-title":"New clinical diagnostic criteria for allergic bronchopulmonary aspergillosis\/mycosis and its validation","volume":"147","author":"K Asano","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"1709","key":"ref50","first-page":"371","article-title":"Clinical implications of globally emerging azole resistance in Aspergillus fumigatus","volume":"371","author":"J F Meis","year":"2016","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"07","key":"ref51","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/myc.12334","article-title":"Performance of serum galactomannan in patients with allergic bronchopulmonary aspergillosis","volume":"58","author":"R Agarwal","year":"2015","journal-title":"Mycoses"},{"issue":"04","key":"ref52","doi-asserted-by":"crossref","first-page":"2201242","DOI":"10.1183\/13993003.01242-2022","article-title":"Estimating the minimal important difference in FEV1 for patients with allergic bronchopulmonary aspergillosis","volume":"60","author":"R Agarwal","year":"2022","journal-title":"Eur Respir J"},{"issue":"04","key":"ref53","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4103\/0971-3026.90680","article-title":"Pictorial essay: allergic bronchopulmonary aspergillosis","volume":"21","author":"R Agarwal","year":"2011","journal-title":"Indian J Radiol Imaging"},{"issue":"04","key":"ref54","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4329\/wjr.v4.i4.141","article-title":"Chest radiographic and computed tomographic manifestations in allergic bronchopulmonary aspergillosis","volume":"4","author":"R Agarwal","year":"2012","journal-title":"World J Radiol"},{"issue":"12","key":"ref55","doi-asserted-by":"crossref","first-page":"e15346","DOI":"10.1371\/journal.pone.0015346","article-title":"An alternate method of classifying allergic bronchopulmonary aspergillosis based on high-attenuation mucus","volume":"5","author":"R Agarwal","year":"2010","journal-title":"PLoS One"},{"issue":"03","key":"ref56","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1067\/j.cpradiol.2015.07.006","article-title":"High-attenuation mucus impaction in patients with allergic bronchopulmonary aspergillosis: objective criteria on high-resolution computed tomography and correlation with serologic parameters","volume":"45","author":"S Phuyal","year":"2016","journal-title":"Curr Probl Diagn Radiol"},{"issue":"07","key":"ref57","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4329\/wjr.v3.i7.178","article-title":"Allergic bronchopulmonary aspergillosis: lessons for the busy radiologist","volume":"3","author":"R Agarwal","year":"2011","journal-title":"World J Radiol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejrad.2018.12.021","article-title":"Evaluation of 3\u2009T lung magnetic resonance imaging in children with allergic bronchopulmonary aspergillosis: pilot study","volume":"111","author":"K S Sodhi","year":"2019","journal-title":"Eur J Radiol"},{"issue":"04","key":"ref59","doi-asserted-by":"crossref","first-page":"405","DOI":"10.7326\/0003-4819-86-4-405","article-title":"Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis","volume":"86","author":"M Rosenberg","year":"1977","journal-title":"Ann Intern Med"},{"issue":"08","key":"ref60","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/cea.12141","article-title":"Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria","volume":"43","author":"R Agarwal","year":"2013","journal-title":"Clin Exp Allergy"},{"issue":"11","key":"ref61","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJM200003163421102","article-title":"A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis","volume":"342","author":"D A Stevens","year":"2000","journal-title":"N Engl J Med"},{"issue":"05","key":"ref62","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1067\/mai.2003.1388","article-title":"Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial","volume":"111","author":"P A Wark","year":"2003","journal-title":"J Allergy Clin Immunol"},{"issue":"02","key":"ref63","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1183\/13993003.01475-2015","article-title":"A randomised trial of glucocorticoids in acute-stage allergic bronchopulmonary aspergillosis complicating asthma","volume":"47","author":"R Agarwal","year":"2016","journal-title":"Eur Respir J"},{"issue":"03","key":"ref64","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.chest.2018.01.005","article-title":"A randomized trial of itraconazole vs prednisolone in acute-stage allergic bronchopulmonary aspergillosis complicating asthma","volume":"153","author":"R Agarwal","year":"2018","journal-title":"Chest"},{"issue":"03","key":"ref65","doi-asserted-by":"crossref","first-page":"1801159","DOI":"10.1183\/13993003.01159-2018","article-title":"A randomised trial of voriconazole and prednisolone monotherapy in acute-stage allergic bronchopulmonary aspergillosis complicating asthma","volume":"52","author":"R Agarwal","year":"2018","journal-title":"Eur Respir J"},{"issue":"04","key":"ref66","doi-asserted-by":"crossref","first-page":"2101787","DOI":"10.1183\/13993003.01787-2021","article-title":"A randomised trial of prednisolone versus prednisolone and itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma","volume":"59","author":"R Agarwal","year":"2021","journal-title":"Eur Respir J"},{"issue":"06","key":"ref67","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/thx.45.6.447","article-title":"Controlled trial of natamycin in the treatment of allergic bronchopulmonary aspergillosis","volume":"45","author":"D C Currie","year":"1990","journal-title":"Thorax"},{"issue":"05","key":"ref68","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3109\/02770903.2015.1127935","article-title":"A pilot randomized trial of nebulized amphotericin in patients with allergic bronchopulmonary aspergillosis","volume":"53","author":"B Ram","year":"2016","journal-title":"J Asthma"},{"issue":"02","key":"ref69","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jaip.2014.12.008","article-title":"Clinical efficacy and immunologic effects of omalizumab in allergic bronchopulmonary aspergillosis","volume":"3","author":"A L Voskamp","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"04","key":"ref70","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/myc.12879","article-title":"A randomised trial of vitamin D in acute-stage allergic bronchopulmonary aspergillosis complicating asthma","volume":"62","author":"M H Dodamani","year":"2019","journal-title":"Mycoses"},{"issue":"03","key":"ref72","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jaip.2022.12.012","article-title":"Omalizumab in allergic bronchopulmonary aspergillosis: a systematic review and meta-analysis","volume":"11","author":"M Jin","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"01","key":"ref73","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/jac\/dkaa382","article-title":"Clinical experience with SUBA-itraconazole at a tertiary paediatric hospital","volume":"76","author":"J Abbotsford","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s11046-015-9907-0","article-title":"Acute invasive pulmonary aspergillosis complicating allergic bronchopulmonary aspergillosis: case report and systematic review","volume":"180","author":"V N Maturu","year":"2015","journal-title":"Mycopathologia"},{"issue":"04","key":"ref75","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jcf.2009.04.008","article-title":"Intravenous monthly pulse methylprednisolone treatment for ABPA in patients with cystic fibrosis","volume":"8","author":"M Cohen-Cymberknoh","year":"2009","journal-title":"J Cyst Fibros"},{"issue":"131","key":"ref76","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1183\/09059180.00004813","article-title":"Pulse methylprednisolone in allergic bronchopulmonary aspergillosis exacerbations","volume":"23","author":"I Singh Sehgal","year":"2014","journal-title":"Eur Respir Rev"},{"issue":"10","key":"ref77","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.2217\/fmb.14.74","article-title":"Diagnosis of allergic bronchopulmonary aspergillosis: a case-based approach","volume":"9","author":"S Dhooria","year":"2014","journal-title":"Future Microbiol"},{"issue":"08","key":"ref78","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2169\/internalmedicine.50.4665","article-title":"Role of inhaled corticosteroids in the management of serological allergic bronchopulmonary aspergillosis (ABPA)","volume":"50","author":"R Agarwal","year":"2011","journal-title":"Intern Med"},{"issue":"10","key":"ref79","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S2213-2600(19)30185-7","article-title":"The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis","volume":"7","author":"I F Laska","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"01","key":"ref80","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/0022-3859.128806","article-title":"Role of inhaled amphotericin in allergic bronchopulmonary aspergillosis","volume":"60","author":"I S Sehgal","year":"2014","journal-title":"J Postgrad Med"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"102226","DOI":"10.1016\/j.pupt.2023.102226","article-title":"Nebulized amphotericin B for preventing exacerbations in allergic bronchopulmonary aspergillosis: a systematic review and meta-analysis","volume":"81","author":"V Muthu","year":"2023","journal-title":"Pulm Pharmacol Ther"},{"issue":"01","key":"ref82","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3390\/jof9010085","article-title":"Severe fungal asthma: a role for biologics and inhaled antifungals","volume":"9","author":"R B Moss","year":"2023","journal-title":"J Fungi (Basel)"},{"issue":"25","key":"ref83","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1056\/NEJMoa1703501","article-title":"Oral glucocorticoid-sparing effect of benralizumab in severe asthma","volume":"376","author":"P Nair","year":"2017","journal-title":"N Engl J Med"},{"issue":"07","key":"ref84","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1016\/j.jaip.2020.03.023","article-title":"Mepolizumab for allergic bronchopulmonary aspergillosis: report of 20 cases from the Belgian Severe Asthma Registry and review of the literature","volume":"8","author":"F Schleich","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejim.2021.12.026","article-title":"One-year mepolizumab for allergic bronchopulmonary aspergillosis: focus on steroid sparing effect and markers of response","volume":"99","author":"M Caminati","year":"2022","journal-title":"Eur J Intern Med"},{"issue":"05","key":"ref86","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.jaip.2018.11.024","article-title":"Allergic bronchopulmonary aspergillosis successfully treated with benralizumab","volume":"7","author":"S Soeda","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"09","key":"ref87","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.2169\/internalmedicine.6217-20","article-title":"Successful treatment with benralizumab for allergic bronchopulmonary aspergillosis that developed after disastrous heavy rainfall in western Japan","volume":"60","author":"H Matsuura","year":"2021","journal-title":"Intern Med"},{"issue":"02","key":"ref88","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jaip.2019.11.031","article-title":"Dupilumab treatment for allergic bronchopulmonary aspergillosis: a case series","volume":"8","author":"R P Ramonell","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref89","first-page":"101520","article-title":"Mepolizumab and dupilumab as a replacement to systemic glucocorticoids for the treatment of chronic eosinophilic pneumonia and allergic bronchopulmonary aspergillosis - case series, Almoosa specialist hospital","volume":"34","author":"S AM Eldaabossi","year":"2021","journal-title":"Respir Med Case Rep"},{"issue":"01","key":"ref90","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.alit.2020.08.006","article-title":"Efficacy of dupilumab and biomarkers for systemic corticosteroid na\u00efve allergic bronchopulmonary mycosis","volume":"70","author":"H Tashiro","year":"2021","journal-title":"Allergol Int"},{"issue":"15","key":"ref91","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.2169\/internalmedicine.6807-20","article-title":"Benralizumab as a first-line treatment for ABPA: is it really indicated?","volume":"60","author":"R Agarwal","year":"2021","journal-title":"Intern Med"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/S1569-1993(10)60206-8","article-title":"Voriconazole treatment in CF patients with ABPA and\/or invasive aspergillosis","volume":"9","author":"P Schelstraete","year":"2010","journal-title":"J Cyst Fibros"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1016\/S1569-1993(12)60519-0","article-title":"Effectiveness of omalizumab for treatment of allergic bronchopulmonary aspergillosis (ABPA) among children and adolescents with cystic fibrosis","volume":"11","author":"E Hatziagorou","year":"2012","journal-title":"J Cyst Fibros"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/S1569-1993(16)30228-4","article-title":"Omalizumab therapy for steroid-dependent ABPA in children with cystic fibrosis: a case series","volume":"15","author":"M Wright","year":"2016","journal-title":"J Cyst Fibros"},{"issue":"07","key":"ref95","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1007\/s12098-023-04592-y","article-title":"Evidence-based guidelines for the management of allergic bronchopulmonary aspergillosis (ABPA) in children and adolescents with asthma","volume":"90","author":"J L Mathew","year":"2023","journal-title":"Indian J Pediatr"},{"issue":"01","key":"ref96","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3109\/1040841X.2012.754401","article-title":"Allergic bronchopulmonary mycosis due to fungi other than Aspergillus: a global overview","volume":"40","author":"A Chowdhary","year":"2014","journal-title":"Crit Rev Microbiol"},{"issue":"01","key":"ref97","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/myc.13180","article-title":"Pregnancy complicated by allergic bronchopulmonary aspergillosis: a case-control study","volume":"64","author":"I S Sehgal","year":"2021","journal-title":"Mycoses"},{"issue":"03","key":"ref98","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2165\/00002018-200932030-00006","article-title":"First-trimester itraconazole exposure and pregnancy outcome: a prospective cohort study of women contacting teratology information services in Italy","volume":"32","author":"M De Santis","year":"2009","journal-title":"Drug Saf"},{"issue":"02","key":"ref99","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jaci.2014.08.025","article-title":"The Xolair Pregnancy Registry (EXPECT): the safety of omalizumab use during pregnancy","volume":"135","author":"J Namazy","year":"2015","journal-title":"J Allergy Clin Immunol"}],"container-title":["Seminars in Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0043-1776912.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T17:20:57Z","timestamp":1730827257000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0043-1776912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,28]]},"references-count":98,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2024,1,29]]},"published-print":{"date-parts":[[2024,2]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0043-1776912","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1069-3424","1098-9048"],"issn-type":[{"value":"1069-3424","type":"print"},{"value":"1098-9048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,28]]}}}